New Guidelines Advocate Earlier HIV Treatment

KUALA LUMPUR — New international guidelines suggest that people diagnosed with human immunodeficiency virus (HIV) be treated earlier in the course of the disease — effectively making another 9.2 million people eligible for antiretroviral therapy, researchers said here.

“Generally, in the U.S. and Canada we are already using these guidelines to treat our patients,” Julio Montaner, MD, professor of medicine at the University of British Columbia, Vancouver, told MedPage Today.

“What these guidelines will do, however, is to convince doctors who are on the fence about where to begin treatment to start treating their patients earlier,” Montaner said.

Ed Susman
Contributing Writer
MedPage Today
Read More

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025